Open Trial Databases Not Widely Popular – Yet – Duke Researcher Finds
Executive Summary
For three major databases allowing researcher access to clinical trial data, few requests were to validate results.
You may also be interested in...
TCT 2016: Researchers Argue For More Medtech Data Sharing
Device companies are not stepping up as much as they should be to make their raw trial data available for analysis by independent researchers, cardiologists said at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
GSK’s DoJ Settlement Requires Execs To Forfeit Bonuses If Misconduct Occurs
GlaxoSmithKline pleads guilty to promoting Paxil and Wellbutrin off-label and failing to report Avandia safety data to FDA; civil portion of settlement resolves off-label and kickback allegations involving nine products. New corporate integrity agreement gives OIG authority to require a recall.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.